Us2.ai, a leading MedTech firm, has recently received FDA clearance for its Us2.v2 software, a revolutionary advancement in cardiovascular ultrasound analysis. This software features 45 automated echo parameters, including strain analysis, which marks a significant stride in medical innovation [1].
The Us2.v2 software is designed to aid in the diagnostic review, analysis, and reporting of echocardiographic DICOM images. It automatically generates clinically relevant and reproducible quantitative echocardiographic measurements, reducing analysis time and streamlining the workflow for clinicians [2]. With the ability to generate and edit reports faster and with precision, clinicians can maintain complete control and improve patient care and efficiency.
Building upon the success of its previous FDA-cleared and CE marked solution, Us2.v1, which revolutionized automated clinical workflow for cardiac measurements, Us2.v2 introduces key highlights that enhance the capabilities of cardiovascular ultrasound analysis. These include automated GLS quantification for strain imaging, regional strain detection for coronary artery disease, aortic stenosis measurements following ASE recommendations, comprehensive quantitative analysis of cardiac structure and function, and essential measurements for the detection of conditions such as cardiac amyloidosis and heart failure with preserved ejection fraction [3].
The benefits of the Us2.v2 software are numerous. It offers real-time fully automated image processing and analyses, with less variability compared to human measurement. The output is explainable AI, allowing users to evaluate all automated annotations and measurements. The software also streamlines reporting by automatically generating comprehensive reports and provides decision support tools for qualified sonographers and reviewing physicians to perform edits and revise markup on echocardiographic image measurements [8].
The FDA clearance of Us2.v2 is a significant milestone for Us2.ai and demonstrates their commitment to advancing cardiovascular care through innovative technology. James Hare, the CEO and co-founder of Us2.ai, emphasizes the importance of these advancements for busy clinical practices: “These additions are critical for busy clinical practices looking towards detection of CV diseases such as aortic stenosis, HFpEF, and amyloidosis to provide better and more precise care for patients” [1].
Experts in the field also recognize the impact of automated echo analysis in improving patient care. Justin Ezekowitz, MD, from the Canadian VIGOUR Centre, Faculty of Medicine and Dentistry, University of Alberta, Canada, explains that automation in echocardiography allows more patients to benefit from new advances in targeted therapy and reduces uncertainty in measurement [1].
The Us2.v2 software not only enhances the precision and efficiency of echocardiographic analysis but also ensures high-quality patient care by integrating international guidelines and aligning with the latest clinical standards. Madhav Swaminathan, MD, Associate Professor of Anesthesiology at Duke Medical Center and Past President of the American Society of Echocardiography (ASE), highlights the positive impact of the software on clinical workflow: “By offering advanced capabilities that significantly enhance both precision and efficiency of echocardiographic analysis, this innovation dramatically reduces analysis time, thereby speeding up clinical workflow. This is particularly helpful in clinical states that require additional imaging parameters such as strain or are challenged by variability in interpretation such as aortic stenosis” [1].
Us2.v2 is intended for use in adult patients and aims to support qualified cardiologists, sonographers, or other licensed healthcare practitioners in clinical decision-making processes. This software represents a significant advancement in cardiovascular ultrasound analysis, and its impact on patient care and efficiency is promising.
For more information about Us2.v2 and its impact on cardiovascular ultrasound analysis, visit the Us2.ai website [1].
Use the share button below if you liked it.